Psychopharmacology 2011-08-01

Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.

Matthew L Banks, Peter G Roma, John E Folk, Kenner C Rice, S Stevens Negus

Index: Psychopharmacology 216(3) , 431-9, (2011)

Full Text: HTML

Abstract

Delta-opioid agonists enhance the antinociceptive efficacy of methadone and other mu-opioid agonists. However, relatively little is known about the degree to which delta agonists might enhance the abuse-related effects of mu agonists.This study used a behavioral economic approach to examine effects of the delta agonist SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] on the reinforcing effects of methadone in a drug self-administration assay. Interactions between SNC80 and cocaine were also examined for comparison.Rhesus monkeys (n = 4), surgically implanted with indwelling intravenous catheters, were tested in two phases. In phase 1, drug self-administration dose-effect curves for methadone (0.0032-0.1 mg/kg/injection (inj)) and cocaine (0.0032-0.32 mg/kg/inj) alone were determined under a fixed-ratio 10 (FR 10) schedule of reinforcement. In phase 2, FR values were increased every 3 days (FR 1-FR 1800) during availability of methadone alone (0.032 mg/kg/inj) and in combination with varying proportions of SNC80 (0.1:1, 0.3:1, and 0.9:1 SNC80/methadone) or of cocaine alone (0.032 mg/kg/inj) and in combination with varying proportions of SNC80 (0.33:1, 1:1, and 3:1 SNC80/cocaine). Demand curves related drug intake to FR price, and measures of reinforcement were derived.Methadone and cocaine alone each functioned as a reinforcer. SNC80 did not alter measures of reinforcement for either methadone or cocaine.SNC80 at proportions previously shown to enhance methadone-induced antinociception did not enhance the abuse-related effects of methadone. These results support the proposition that delta agonists may selectively enhance mu agonist analgesic effects without enhancing mu agonist abuse liability.


Related Compounds

Related Articles:

PKA and ERK1/2 are involved in dopamine D₁ receptor-induced heterologous desensitization of the δ opioid receptor.

2013-06-21

[Life Sci. 92(23) , 1101-9, (2013)]

Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling.

2013-01-01

[J. Pharmacol. Exp. Ther. 344(1) , 179-88, (2013)]

Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.

2010-10-01

[J. Pharmacol. Exp. Ther. 335(1) , 133-9, (2010)]

Cholecystokinin receptors mediate tolerance to the analgesic effect of TENS in arthritic rats.

2010-01-01

[Pain 148(1) , 84-93, (2010)]

Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration.

2010-11-01

[Bioorg. Med. Chem. Lett. 20(21) , 6302-5, (2010)]

More Articles...